Table 1.
Characteristic | Number (%) |
---|---|
Total number | 46 |
Male | 21 (45%) |
Race (Caucasian) | 39 (85%) |
Age Diagnosis (yrs) | |
Mean ± SEM | 41.7 ± 2.1 |
[range] | [24-76] |
Type PET | |
NF-PET | 14 (43%) |
Functional PET | 32 (57%) |
Gastrinoma (glucagonoma) | 30 (2)a |
Presenting symptom | |
Due to functional PET | 32 (70%)(b) |
Due to pain | 20 (30%) |
MEN1 present | 12 (26%) |
Duration of symptoms at diagnosis (yrs) (Functional PETs) | |
Mean ± SEM | 5.0 ± 0.9 |
[range] | [0.25-17.9] |
Hormone elevation (fold increase) | |
median | 12(c) |
Mean ± SEM | 292 ± 213 |
[range] | [3-5500] |
Six patients with gastrinomas with MEN1 also had NF-PETs identified preoperatively. Two patients had glucagonoma.
All patients with functional PETs presented with symptoms due to hormone excess state.
Gastrin elevation in the 30 patients with gastrinomas preoperatively